Table 2.

(1) Clotting factors median and 25–75% IQR at admission and mortality in Group 0 and Group 2 (Group 1 values can be found in Table 1 as no deaths were found in this group). (2) Number of patients with altered clotting factors at admission and mortality in group 0 and group 2.

(1)
	Group 0			Group 2
	Survivors	Non-Survivors	p -Value	Survivors	Non-Survivors	p -Value
Platelets (10⁹ cells/L) n.v. 130–430	234 (196–274)	179 (139–227)	<0.01	236(175–301)	150 (145–155)	0.1671
INR n.v. 0.80 – 1.20	1.08 (1.03–1.15)	1.35 (1.11–1.51)	<0.001	1.12 (1.08–2.42)	4.94 (4.57–5.32)	<0.05
aPTT (seconds) n.v. 28 – 40	29 (26.8–31.6)	30.7 (28.9–33)	<0.05	32(27.6–47.1)	42.15 (34.9–49.4)	0.4298
Fibrinogen (g/L) n.v. 2.0 – 4.0	2.60 (2.23–3.05)	1.81 (1.12–2.35)	<0.01	3.68 (2.27–3.88)	2.22 (1.55–2.90)	0.2482
(2)
	Group 0			Group 2
	Survivors	Non-Survivors	p -Value	Survivors	Non-Survivors	p -Value
Altered PLT	11 (3.7%)	2 (13.3%)	0.072	1 (9.1%)	0	0.657
Altered INR	40 (13.8%)	9 (60%)	<0.01	7 (63.64%)	2 (100%)	0.305
Altered aPTT	108 (38%)	4 (26.7%)	0.376	6 (54.5%)	1 (50%)	0.906
Altered Fibrinogen	32 (25.8%)	4 (50%)	0.136	0 (-)	1 (50%)	0.171

(1) Abbreviations: INR = international normalized ratio; n.v. = normal values. (2) Data are presented as number of patients count and %. Abbreviations: PLT: platelets; INR = International Normalized Ratio.